Danielle Brill
Stock Analyst at Raymond James
(0)
# 4395
Out of 5,298 analysts
88
Total ratings
26.92%
Success rate
-15.83%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
QURE uniQure | Upgrades: Strong Buy | 20 52 | 9.17 | 467.07% | 6 | Dec 10, 2024 | |
TECX Tectonic Therapeutic | Initiates Coverage On: Outperform | 65 | 15.9 | 308.81% | 1 | Nov 20, 2024 | |
DNLI Denali Therapeutics | Reinstates: Market Perform | n/a | n/a | n/a | 1 | Oct 10, 2024 | |
BMRN Biomarin Pharmaceuti... | Reinstates: Outperform | 79 | 63.99 | 23.46% | 1 | Oct 10, 2024 | |
RGNX Regenxbio | Reinstates: Outperform | 18 | 6.47 | 178.21% | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 155 | 96.65 | 60.37% | 5 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 36 | 14.77 | 143.74% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 40 | 29.63 | 35% | 7 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 150 | 57.93 | 158.93% | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Strong Buy | 605 | 575.04 | 5.21% | 7 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 5 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 50 | 30.64 | 63.19% | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 51 | 26.46 | 92.74% | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 43 | 43.22 | -0.51% | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 5 | 0.36 | 1288.89% | 5 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 9 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Oct 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 75 50 | n/a | n/a | 5 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Aug 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Aug 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Sep 17, 2019 |